Rob Chess

Rob Chess serves as Chairman (1999-present), CEO (1992-99, 2006-7), President (1991-92) at Nektar Therapeutics. Nektar Therapeutics operates in the biotechnology sector with approximately 620.0 employees. The company is headquartered in San Francisco, California. Nektar Therapeutics generates annual revenue of 98400000.0.

Industry & Role Insights

• • MessageCEO tracks 381 executives in the biotechnology sector.
• • We have verified contacts for 2 executives at Nektar Therapeutics.
• • 13,743 executive contacts are available in California.
• • Our database includes 201,469 c suite-level executives.

Mimecast Outlook Microsoft Office 365 Google Cloud Hosting Drupal VueJS Adobe Media Optimizer New Relic Google Font API Taleo Google Tag Manager Nginx WordPress.org reCAPTCHA Cedexis Radar Vimeo ShareThis Mobile Friendly Remote

drug development & polymer conjugate chemistry biotechnology life sciences biotechnology: pharmaceutical preparations health care biopharmaceutical novel therapies immune modulation autoimmune disorders chronic inflammatory conditions immuno-oncology clinical trials expanded access investigational medicines pipeline therapeutic benefit polymer chemistry scientific publications medical events patient care t regulatory cells il-15 pathway nktr-214 nktr-255 rezpeg peg-csf1 tnfr-2 healthcare conferences research & development pharmaceutical partners stock information financial filings corporate governance investor relations business development strategic initiatives drug development regulatory expertise clinical strategy medical affairs clinical investigator biologics safety & efficacy patient outcomes therapeutic agents integrated solutions healthcare innovations drug discovery life-changing medicines disease management treatment advancements healthcare market cancer therapies biopharmaceuticals clinical-stage chronic inflammation pegylation polymer conjugate technology rezpegaldesleukin investigational drugs regulatory t cells immunology patient-centric innovative therapies unmet medical needs partnerships pharmaceutical collaborations healthcare providers patient demographics chronic diseases immune system balance therapeutic benefits healthcare innovation r&d pipeline immune-related diseases market strategy patient populations flexible work culture employee benefits corporate challenges leadership issues recent collaborations diabetes research clinical trial network health wellness & fitness hospital & health care b2b

EI

Ehud Ivri CTO at Nektar Therapeutics

CB

Chip Baird Chief Executive Officer at 2seventy bio at 2seventy bio

JL

Jason Loveridge CEO at 4SC AG

MM

Marie Moores Chief Operating Officer at AB Cavalli Coach & Consultant

JR

Julie Rubinstein President and Chief Operating Officer at Adaptive Biotechnologies Corp.

Outreach Guidance — biotechnology Sector

Technology executives make decisions on infrastructure, tooling, and partnerships. When reaching out to Rob Chess, lead with your value proposition relative to the stack they currently use. Generic pitches perform poorly; specific technical relevance is key.

Rob Chess's Position in the MessageCEO Database

• •Rob Chess is 1 of 2 verified executive contacts we track at Nektar Therapeutics.
• •365 verified executive contacts in biotechnology are in the MessageCEO database.
• •12,901 verified executive contacts in California are in the database.
• •4 verified contacts work at biotechnology companies in the 620.0 employee range (same size as Nektar Therapeutics).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.

How do I reach Rob Chess directly?

Rob Chess's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chairman (1999-present), CEO (1992-99, 2006-7), President (1991-92) at Nektar Therapeutics. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Rob Chess work for?

Rob Chess is Chairman (1999-present), CEO (1992-99, 2006-7), President (1991-92) at Nektar Therapeutics, a company in the biotechnology sector with 620.0 employees. The company is based in San Francisco, California.

Can I pitch or sell to Rob Chess?

As Chairman (1999-present), CEO (1992-99, 2006-7), President (1991-92) at Nektar Therapeutics, Rob Chess is a key decision-maker in the biotechnology sector. MessageCEO Pro gives you verified email to reach Rob Chess directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Rob Chess in?

Rob Chess works in the biotechnology industry as Chairman (1999-present), CEO (1992-99, 2006-7), President (1991-92) at Nektar Therapeutics. MessageCEO provides verified contact information for executives across all major industries.

Is Rob Chess's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Rob Chess's profile is kept up-to-date with the latest available information.

Last updated: July 23, 2026